Literature DB >> 18058411

Withdrawal symptoms do not predict relapse among subjects treated for cannabis dependence.

Mikkel Arendt1, Raben Rosenberg, Leslie Foldager, Leo Sher, Povl Munk-Jørgensen.   

Abstract

This is the first follow-up study on the association between cannabis withdrawal symptoms and risk of relapse to cannabis use. Withdrawal symptoms were assessed in 36 subjects seeking treatment for cannabis dependence. All were free of other substance use or alcohol abuse in the month before abstinence from cannabis. Follow-up was performed 26+/-4 months later, and at this point, the withdrawal symptoms were re-assessed. The following symptoms were significantly elevated after abstinence compared with follow-up: irritability, anger, depression, restlessness, craving, sleep problems, strange dreams, increased appetite, violent outbursts, sweating, hot flashes, chills, and shakiness. This offers further validation of a cannabis withdrawal syndrome. Average withdrawal scores at baseline did not differ with gender, age, treatment type, extent of cannabis use, or a lifetime history of anxiety or affective disorders. Withdrawal scores at baseline did not predict relapse during follow-up.

Entities:  

Mesh:

Year:  2007        PMID: 18058411     DOI: 10.1080/10550490701640985

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  16 in total

1.  Diagnostic criteria for cannabis withdrawal syndrome.

Authors:  David A Gorelick; Kenneth H Levin; Marc L Copersino; Stephen J Heishman; Fang Liu; Douglas L Boggs; Deanna L Kelly
Journal:  Drug Alcohol Depend       Date:  2011-12-07       Impact factor: 4.492

2.  DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adults.

Authors:  Ofir Livne; Dvora Shmulewitz; Shaul Lev-Ran; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2018-10-22       Impact factor: 4.492

3.  Sociodemographic characteristics of cannabis smokers and the experience of cannabis withdrawal.

Authors:  Marc L Copersino; Susan J Boyd; Donald P Tashkin; Marilyn A Huestis; Stephen J Heishman; John C Dermand; Michael S Simmons; David A Gorelick
Journal:  Am J Drug Alcohol Abuse       Date:  2010-08-03       Impact factor: 3.829

4.  Drug- and cue-induced reinstatement of cannabinoid-seeking behaviour in male and female rats: influence of ovarian hormones.

Authors:  L Fattore; M S Spano; S Altea; P Fadda; W Fratta
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

5.  Cannabis withdrawal in chronic cannabis users with schizophrenia.

Authors:  Douglas L Boggs; Deanna L Kelly; Fang Liu; Jared A Linthicum; Hailey Turner; Jennifer R Schroeder; Robert P McMahon; David A Gorelick
Journal:  J Psychiatr Res       Date:  2012-11-10       Impact factor: 4.791

6.  Cannabis Withdrawal, Posttreatment Abstinence, and Days to First Cannabis Use Among Emerging Adults in Substance Use Treatment: A Prospective Study.

Authors:  Jordan P Davis; Douglas C Smith; Jason W Morphew; Xinrong Lei; Saijun Zhang
Journal:  J Drug Issues       Date:  2016-01

7.  Probability and predictors of cannabis use disorders relapse: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).

Authors:  Ludwing Flórez-Salamanca; Roberto Secades-Villa; Alan J Budney; Olaya García-Rodríguez; Shuai Wang; Carlos Blanco
Journal:  Drug Alcohol Depend       Date:  2013-02-15       Impact factor: 4.492

Review 8.  Marijuana dependence: not just smoke and mirrors.

Authors:  Divya Ramesh; Joel E Schlosburg; Jason M Wiebelhaus; Aron H Lichtman
Journal:  ILAR J       Date:  2011

Review 9.  Norepinephrine and stimulant addiction.

Authors:  Mehmet Sofuoglu; R Andrew Sewell
Journal:  Addict Biol       Date:  2008-09-22       Impact factor: 4.280

Review 10.  Self-administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfalls.

Authors:  Margaret Haney
Journal:  Addict Biol       Date:  2008-10-09       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.